Is fibrinolytic therapy really safe in the treatment of prosthetic valve thrombosis in patients with high INR?-Reference-Cited by-同舟云学术

Is fibrinolytic therapy really safe in the treatment of prosthetic valve thrombosis in patients with high INR?

Published:2020-11-10 Issue:2 Volume:36 Page:779-780
ISSN:0886-0440
Container-title:Journal of Cardiac Surgery
language:en
Short-container-title:J Card Surg

Author:

Güner Ahmet¹^ORCID,Kalçık Macit²^ORCID,Gündüz Sabahattin³,Gürsoy Mustafa Ozan⁴,Özkan Mehmet⁵

Affiliation:

1. Department of Cardiology Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital University of Health Sciences Istanbul Turkey

2. Department of Cardiology Faculty of Medicine Hitit University Corum Turkey

3. Department of Cardiology Faculty of Medicine Bahcesehir University Istanbul Turkey

4. Department of Cardiology Atatürk Training and Research Hospital Izmir Katip Çelebi University Izmir Turkey

5. School of Health Sciences Ardahan University Ardahan Turkey

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Surgery,Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jocs.15193

Reference7 articles.

1. Safety of thrombolytic therapy in patients with prosthetic heart valve thrombosis who have high international normalized ratio levels

2. How to perform and manage low-dose and slow/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis

3. Thrombolytic Therapy for the Treatment of Prosthetic Heart Valve Thrombosis in Pregnancy With Low-Dose, Slow Infusion of Tissue-Type Plasminogen Activator

4. Comparison of Different TEE-Guided Thrombolytic Regimens for Prosthetic Valve Thrombosis

5. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease